Excess weight may ward off infection in breast cancer treatmentJune 7, 2022Breast CancerASCO Breast CancerMetastatic Breast Cancer
Women with HER2+ metastatic breast cancer are living longerJune 7, 2022ASCO Breast CancerBreast CancerMetastatic Breast Cancer
Treating bone loss ups survival for breast cancer patientsJune 6, 2022ASCO Breast CancerBreast CancerMetastatic Breast Cancer
Pembrolizumab before surgery improves survival in early triple negative breast cancerJune 5, 2022ASCO Breast CancerBreast CancerMetastatic Breast Cancer
New treatment outperforms chemo in HER2-low breast cancerJune 5, 2022ASCO Breast CancerBreast CancerMetastatic Breast Cancer
New treatment meets unmet need in breast cancerJune 5, 2022ASCO Breast CancerBreast CancerMetastatic Breast Cancer
Oncologists flock to Chicago for ASCO, after 2 years onlineJune 3, 2022ASCO Breast CancerASCO Lung Cancer
Rapid update to ASCO breast cancer guidelines after OlympiA dataJune 22, 2021Breast CancerASCO Breast Cancer
Promising HER2+/HR– breast cancer survival with de-escalated therapyJune 15, 2021Breast CancerASCO Breast Cancer
CONCERT: Better QoL but not survival with cabazitaxel in metastatic HER2– breast cancerJune 7, 2021Breast CancerASCO Breast CancerMetastatic Breast Cancer
Genomic signature predicts safety of omitting RT in early breast cancerJune 7, 2021Breast CancerASCO Breast Cancer
ACE inhibitor prevents trastuzumab-associated LVEF decline after anthracyclines in BC treatmentJune 7, 2021Breast CancerPreventive CareASCO Breast Cancer
Pregnancy effect on chemotherapy does not affect maternal breast cancer outcomesJune 7, 2021Breast CancerASCO Breast Cancer
